Some serum biomarkers as myoglobin and Cyst-C as markers of kidney injury could be assessed in future studies as well as other novel subclinical AKI markers as NGAL and KIM-1 should be assessed in future studies in order to confirm kidney structural damage and early detect AKI [34,61]. The gene discussed is MB; the disease is acute kidney injury.